Page 9 - Pharmaceutical Development News Today

– Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead –FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development a...

Salt lake City, Utah (PRWEB) May 23, 2022 -- EVŌQ Bio, an early-stage pharmaceutical company developing novel therapeutics against bacterial and fungal

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

NEW YORK, NY, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York-based...

Exclusive 5-stream event to meet experts from academia, pharma and bio-pharma under one roof.

See how reputation for quality and experience with antibodies were driving forces in the CDMO selection for a CPI-006 antibody program.


/PRNewswire/ -- The "2022 Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.coms offering. Are you tasked with...

Conference Call and Live Audio Webcast Scheduled for Monday, March 28, 2022, at 10:00 a.m. ET Corporate Highlights Reconstituted Board and appointed Wendy...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New York, NY, March 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based...